Powder extensively hydrolysed formula (0913101) vs Liquid additive lactase (0913121)
Powder extensively hydrolysed formula (0913101) was dispensed 142.0× as often as Liquid additive lactase (0913121) in May 2026 — 38,771 items versus 273 in England.
Powder extensively hydrolysed formula (0913101) · May 2026
NHSBSA Prescription Cost Analysis
Liquid additive lactase (0913121) · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Powder extensively hydrolysed formula (0913101) versus Liquid additive lactase (0913121): national items dispensed by month
▬ Powder extensively hydrolysed formula (0913101) · ╌ Liquid additive lactase (0913121)
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Powder extensively hydrolysed formula (0913101) | Liquid additive lactase (0913121) |
|---|---|---|
| Items, May 2026 | 38,771 | 273 |
| Items, last 12 months | 486,570 | 4,146 |
| Net ingredient cost, May 2026 | £2,918,919 | £3,931 |
See the full profile for Powder extensively hydrolysed formula (0913101) or Liquid additive lactase (0913121).